Energenesis Biomedical CO.,LTD. (TPE:6657)

TPE:6657 Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 22, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,321	3,872	4,592	2,858	2,997	2,926
Market Cap Growth	30.85%	-15.67%	60.69%	-4.64%	2.41%	-38.41%
Enterprise Value	5,326	3,323	3,849	2,303	2,521	2,359
Last Close Price	71.30	50.80	59.32	41.99	44.34	48.23
PS Ratio	836.82	499.70	641.51	388.74	400.14	413.25
PB Ratio	5.86	5.24	5.71	4.74	3.52	4.35
P/TBV Ratio	5.92	5.34	5.91	5.07	3.74	4.81
EV/Sales Ratio	-	428.78	537.71	313.26	336.60	333.11
Debt / Equity Ratio	0.01	0.01	0.01	0.02	0.01	0.02
Asset Turnover	0.01	0.01	0.01	0.01	0.01	0.01
Inventory Turnover	2.42	2.78	2.93	3.43	3.04	2.76
Quick Ratio	27.00	19.06	33.49	20.43	27.01	24.24
Current Ratio	27.52	19.19	33.71	20.67	27.16	24.33
Return on Equity (ROE)	-30.84%	-29.95%	-37.02%	-36.52%	-15.77%	-17.74%
Return on Assets (ROA)	-19.53%	-19.82%	-22.43%	-22.39%	-9.59%	-10.99%
Return on Capital (ROIC)	-20.10%	-20.42%	-22.98%	-23.00%	-9.83%	-11.23%
Earnings Yield	-4.51%	-5.97%	-5.67%	-9.30%	-4.01%	-4.42%
FCF Yield	-3.74%	-4.69%	-4.92%	-8.37%	-3.54%	-3.54%
Buyback Yield / Dilution	-6.35%	-5.97%	-8.08%	-10.96%	-1.67%	-12.43%

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.